Breast diseases Flashcards
1
Q
Non-cancerous breast lump
- Fibroadenoma - histology
- Description
- Excision indication
- Fibroadenosis - symptoms
- Relate to what
- Management options
- Breast cyst - description
- Fat necrosis - description
9 Associations - Lipoma - description
- Phyllodes tumour - MAYBE MALIGNANT (25%)
A
- From stromal/epithelial breast duct tissue
- Discrete, non-tender, smooth, well circumscribed, firm, highly mobile (‘breast mice’), 3cm, women <30,
Smaller after menopause (hormone dependent) - If >3cm
- Bilateral lumps/pain/tenderness, size fluctuates
- Menstruation (start 10 days before, resolve after)
- Stop hormonal contraception, NSAIDs, weight loss
- Fluid filled, smooth, well circumscribed, mobile, possibly fluctuant (size/location), occur aged 30-60 yo. ‘Halo sign’ on mammogram
- Firm, round/irregular, fixed, dimpling, nipple inversion
- Local trauma/surgery; oil cyst (contains emulsified fat), obese women, large breasts
- Fat collection, soft, painless, mobile, up to 20cm
- Large, fast growing periductal stromal cell, 40-50yo
2
Q
Referrals
- 2ww - definite indications (3)
- Triple assessment comprises of
- 2ww - consider (2)
- Non-urgent
A
- 30+ and unexplained breast lump with/without pain
50+ and unilateral nipple discharge/retraction
Previous breast cancer with new suspicious symptoms - Clinical Assessment
Breast Imaging (ultrasound or mammography)
Biopsy (fine needle aspiration or core biopsy) - Skin changes suggestive of breast cancer
30+ and unexplained axilla lump with/without pain - <30 and unexplained breast lump with/without pain
3
Q
Breast cancer
- Suspicious symptoms
- Associated genes
- Metastasis sites (2 Ls, 2 Bs)
A
- Hard, irregular, painless, fixed, skin/chest wall tethered, nipple retraction, skin dimpling/oedema (peau d’orange)
2. BRCA 1 (chromosome 17) - 60% breast, 40% ovarian BRCA 2 (chromosome 13) - 40% breast, 15% ovarian
- Lung, liver, bone, brain
4
Q
Breast screening
- When
- Benefits (2)
- Harm (6)
- Call back rate
A
- Every 3 years from 47-73 yo
- Earlier detection leading to:
Reduction in mortality (biggest reduction aged 50-70) More breast-conserving treatment (less mastectomies) - Over-diagnosis (so unnecessary treatment)
False-positive mammograms (unnecessary further tests)
False reassurance if missed cancer + incorrect diagnosis
Mammography - pain/discomfort
Psychological distress
Radiation exposure (may increase breast cancer risk) - 1 in 25 (and 1 in 4 of those have cancer)
5
Q
Breast pain
- Management - conservative
- Medical
A
- Well fitting bra, diet, exercise
2. Topical NSAIDS, change OCP if pain is linked, consider hormone suppressing drugs if severe and prolonged
6
Q
Mastitis
- Symptoms/signs
- How common in breastfeeding women
- 1st line management if uncomplicated
- Indications for ABX therapy
- Commonest organism if infective
- ABX management
- Complication + signs of this
A
- Tender, warm, erythematous, thickened tissue, pain/burning whilst breastfeeding
- 1 in 10
- Continue breastfeeding
- If systemically unwell / nipple fissure present / no improvement after 12-24 hours of effective milk removal / culture indicates infection
- Staph. aureus
- Flucloxacillin PO 10-14 days
- Abscess - fever, pus discharge, local erythema, pain, heat
7
Q
Breast cancer - ductal carcinoma
- Commonest of all breast cancers
- Ductal carcinoma in situ (DCIS) - meaning
- Management options
A
- Invasive ductal carcinoma (‘No Special Type/NST’)
- Hasn’t spread beyond local tissue - ‘comedo necrosis not breaching basement membrane’
- Low risk - excise (1cm margins) and radiotherapy, middle/high/multifocal - mastectomy (lower recurrence)
8
Q
Nipple discharge - benign differentials
- Mammary Duct Ectasia (MULTIPLE ducts) - discharge
- Other symptoms
- Major risk factor
- Management
- Complication
- Duct/Intraductal Papilloma - (ONE duct) - discharge
- Timing of presentation
- Investigation
- Management
- Breast abscess - presentation
A
- Thick green/brown, sometimes bloody
- Mastalgia (non-cyclical), nipple inversion/retraction, sometimes tender palpable subareolar mass
- Smoking, peri-menopausal
- Conservative (settles spontaneously), excision if persistent
- Rupture - inflamed - ‘plasma cell/periductal mastitis’
- Serous/bloody discharge
- Post-menopause
- Breast ductography (via contrast injection) shows small (2-3mm wart-like lesion within duct)
- Excision and vigilant breast screening (can increase risk of breast cancer as hyperplastic)
- Fever, pus discharge, local erythema, pain, heat
9
Q
Galactorrhoea (lactation)
- Occurs due to what, released from what, stopped by what
- Timing related to pregnancy
- Idiopathic - cause, management
- Prolactinoma (pituitary gland tumuor) - symptoms
- Management
- Drug causes
- Endocrine causes (4)
- Other causes (2)
A
- Prolactin from anterior pituitary (dopamine suppresses this)
- 2nd trimester to 2 years post-birth
- Prolactin high but no mass, give bromocriptine (dopamine agonist)
- 20-40 yo, gynaecomastia, impotence, amenorrhoea, infertility, bitemporal hemianopia
- Bromocriptine / surgery
- Dopamine antagonists (antipsychotics, domperidone, metoclopramide), female contraceptives, SSRIs, methyldopa, b-blockers, digoxin, spironolactone
- Hypothyroid, acromegaly, Cushing’s, PCOS
- Liver failure, CKD
10
Q
Breast cancers - other
- Lobular carcinoma in situ (LCIS) = aka
- Occurs in who
- Symptoms
- Management
- 30% progress to, + problem with this
- Inflammatory - presentation
- Prognosis compared to other cancers
- Paget’s disease of nipple - presentation
- May represent
A
- Lobular neoplasia
- Pre-menopausal
- Asymptomatic, diagnosed incidentally on breast biopsy
- 6 monthly examination, yearly mammograms
- Invasive lobular carcinoma - not always visible on mammograms
- Similar to mastitis / breast abscess but does not respond to ABX - swollen, warm, tender breast with pitting skin (peau d’orange)
- Worse
- Starts on nipple and spreads to areola - unilateral erythematous, scaly rash, bloody discharge, underlying lump - 2ww
- Invasive ductal carcinoma (90%) / DCIS (10%)
11
Q
Triple assessment
- Clinical - suspicious symptoms
- Imaging - type if <30 + advantages of this
- Type if >30 and advantages of this
- Finding in extracapsular ruptured implant
- Lump biopsy - assesses for what
- Lymph node - if none abnormal found on assessment, do what
- Triple negative meaning
A
- Hard, irregular, painless, fixed, skin/chest wall tethered, nipple retraction, skin dimpling/oedema (peau d’orange)
- USS, distinguishes solid lumps (e.g. fibroadenoma / cancer) from cystic lumps
- Mammography, picks up calcifications missed by ultrasound
- ‘Snowstorm’ sign on USS of axilliary lymph nodes
- ER and HER2 status
- Pre-surgery axilliary USS, then sentinel node biopsy
- No HER, ER, PR receptors
12
Q
Breast cancer - management
- Wide local excision - indications
- Mastectomy - indications
- Axilliary clearance - when, side effect
- Radiotherapy (3-5 weeks) - type if WLE
- Indication if post-mastectomy
- ER+ - hormonal therapy
- Tamoxifen SEs - higher risk of what (3)
- HER2+ - management + contraindication
- Side effects of HER2+ management
- Chemotherapy - indication
- Imaging if neo-adjuvant
- Follow-up
A
- Solitary, peripheral, small in large breast, DCIS <4cm
- Multifocality, local recurrence, DCIS / invasion >4cm
- If disease in nodes; risk of chronic lymphoedema
NOT if isolated tumour cell / ‘micrometastases’ - Whole breast - may reduce recurrence by 2/3
- T3-T4 tumours / 4+ positive axilliary nodes
- Tamoxifen unless post-menopause (then anastrozole, exemestane or letrozole)
- Endometrial cancer, VTE, menopausal symptoms
- Herceptin (trastuzumab) - not if heart disease
- Diarrhoea, tumour pain, headaches
- To downstage a primary lesion, or post-surgery if axilliary node disease (FEC-D chemotherapy if hormone negative but node positive)
- MRI (before, during, after)
- No screening if total mastectomy, yearly for 5 years otherwise, then tailor accordingly